Chief Technology Officer Ben Mabey announces Recursion's new public application for drug discovery, MolRec, and corresponding RxRx3 dataset at Download Day 2023.
About Recursion:
Recursion is a clinical-stage biotechnology company that aims to decode biology to radically improve lives.
Recursion is harnessing the convergence of multiple breakthrough technologies that allow scientists to explore uncharted areas of biology and unravel its complexity to navigate the path to better treatments. The company has built a massive proprietary biological and chemical database that predicts trillions of relationships across biology and chemistry, many of which are not known in scientific literature. This approach generates novel insights, broadens the scope of potential medicines, and truly industrializes drug discovery – increasing the scale, speed and efficiency of each step of the process.
Recursion believes its technology and approach has the potential to not only radically improve the lives of patients, but also change the landscape of drug discovery and development forever.
Visit [ Ссылка ] to learn more.
#biology #chemistry #data #datascience #drugdiscovery #biotech #biotechnology #healthcare #health #medicine #ai #artificialintelligence #machinelearning #ml
